[Expert Solution]: Mr

Mr. Walsh is a 43-year-old male presenting with severe dyspnea plus headache, sore throat, and palpitations. He can barely breathe or talk. He was diagnosed with exercise-induced asthma at the age of 16, which has been controlled with albuterol until he had viral pneumonia 4 months ago. He now has dyspnea even at rest. 1. Which of Mr. Walsh’s symptoms is most important to address first? 2. What important questions should you ask Mr. Walsh about his albuterol use before you administer additional medications? 3. To address the client’s dyspnea, the NP has orders ipratropium (Atrovent) via nebulizer. Based on the NPs orders, which tests will need to done to monitor the drugs effectiveness? 4. Discuss ipratropium (Atrovent) including therapeutic and pharmacological classification, indications for use, therapeutic effects, mechanism of action, adverse effects, black box warnings, contraindications, interactions, pregnancy concerns, important patient education and priority nursing assessments for clients taking this medication. 5. What would be the rationale for the NP to prescribe this medication for Mr. Walsh rather than a short-acting beta-adrenergic agonist? 6. If Mr. Walsh continues to have difficulty breathing, what additional class of medications might the NP consider to manage this client’ symptoms? This could include acute management and/or maintenance medications for asthma.